Cannabinoids: Is there a potential treatment role in epilepsy?

Expert Opinion on Pharmacotherapy

Volumn 16, Issue 13, 2015, Pages 1911-1914

  Blair, Robert E ^a   Deshpande, Laxmikant S ^a   Delorenzo, Robert J ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

cannabidiol; cannabinoids; clinical trials; endocannabinoid; epilepsy; phytocannabinoids; seizure; treatment

Indexed keywords

ANTICONVULSIVE AGENT; CANNABINOID DERIVATIVE; ENDOCANNABINOID; MEDICAL CANNABIS; CANNABINOID; CANNABINOID 1 RECEPTOR;

ANTICONVULSANT ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EPILEPSY; HUMAN; NONHUMAN; REVIEW; SEIZURE; SYNAPTIC TRANSMISSION; AGONISTS; ANIMAL; BRAIN; PATHOPHYSIOLOGY; SEIZURES;

ANIMALS; ANTICONVULSANTS; BRAIN; CANNABINOIDS; EPILEPSY; HUMANS; MEDICAL MARIJUANA; RECEPTOR, CANNABINOID, CB1; SEIZURES;

EID: 84939776727     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2015.1074181     Document Type: Review

References (22)

1. Mechoulam R, Parker LA. The endocannabinoid system and the brain. Annu Rev Psychol 2013; 64: 21-47
2. Dos Santos RG, Hallak JE, Leite JP, et al. Phytocannabinoids and epilepsy. J Clin Pharm Ther 2015; 40 (2): 135-43
3. Blair RE, Deshpande LS, Delorenzo RJ. Endocannabinoids and epilepsy. In: Fattore L.,. editors. Cannabinoids in neurologic and mental disease. 1st edition. Academic Press, Waltham, MA, USA; 2015: 125-72
4. Gloss D, Vickrey B. Cannabinoids for epilepsy. Cochrane Database Syst Rev 2014; 3: CD009270
5. Gross DW, Hamm J, Ashworth NL, Quigley D. Marijuana use and epilepsy: prevalence in patients of a tertiary care epilepsy center. Neurology 2004; 62 (11): 2095-7
6. Swift W, Wong A, Li KM, et al. Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile. PLoS ONE 2013; 8 (7): e70052
7. Wade DT, Makela PM, House H, et al. Long-Term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. Mult Scler 2006; 12 (5): 639-45
8. Hegde M, Santos-Sanchez C, Hess CP, et al. Seizure exacerbation in two patients with focal epilepsy following marijuana cessation. Epilepsy Behav 2012; 25 (4): 563-6
9. Wilkinson ST, Radhakrishnan R, DSouza DC. Impact of cannabis use on the development of psychotic disorders. Curr Addict Rep 2014; 1 (2): 115-28
10. Kuepper R, van Os J, Lieb R, et al. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ 2011; 342: d738
11. Stone JM, Fisher HL, Major B, et al. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation. Psychol Med 2014; 44 (3): 499-506
12. Bui QM, Simpson S, Nordstrom K. Psychiatric and medical management of marijuana intoxication in the emergency department. West J Emerg Med 2015; 16 (3): 414-17
13. Turu G, Hunyady L. Signal transduction of the CB1 cannabinoid receptor. J Mol Endocrinol 2010; 44 (2): 75-85
14. Braakman HM, van Oostenbrugge RJ, van Kranen-Mastenbroek VH, de Krom MC. Rimonabant induces partial seizures in a patient with a history of generalized epilepsy. Epilepsia 2009; 50 (9): 2171-2
15. Blair RE, Deshpande LS, Sombati S, et al. Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy. Neuropharmacology 2009; 57 (3): 208-18
16. Bialer M, Johannessen SI, Levy RH, et al. Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII). Epilepsy Res 2015; 111: 85-141
17. Maa E, Figi P. The case for medical marijuana in epilepsy. Epilepsia 2014; 55 (6): 783-6
18. Porter BE, Jacobson C. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy Behav 2013; 29 (3): 574-7
19. Press CA, Knupp KG, Chapman KE. Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy. Epilepsy Behav 2015; 45: 49-52
20. Cilio MR, Thiele EA, Devinsky O. The case for assessing cannabidiol in epilepsy. Epilepsia 2014; 55 (6): 787-90
21. Devinsky O, Sullivan J, Friedman D, et al. Epidiolex (cannabidiol) in treatment-resistant epilepsy. AAN 67th Annual Meeting Abstract American Academy of Neurology. Washington, DC; 2015
22. Geffrey AL, Pollack SF, Bruno PL, Thiele EA. Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy. Epilepsia 2015. [Epub ahead of print]